@keystonenewsroom Women across Pennsylvania will soon have access to new healthcare services, thanks to a new program from Gov. Josh Shapiro’s administration. The Women’s Service Program seeks to provide healthcare to pregnant and parenting women. Some services include: parenting education programming, sexually-transmitted infection testing and treatment, detection and prevention care and assistance for other physical or behavioral care needs. Pennsylvania Department of Human Services Secretary Val Arkoosh talked to The Keystone about the program at a reproductive healthcare roundate at the Pennsylvania State Capitol in Harrisburg on Friday. The program was created with funding that once went to Real Alternatives, a network of anti-abortion crisis pregnancy centers. Shapiro announced in August that his administration would cancel the organization’s contract with the commonwealth once it expired at the end of 2023. ✏️ 🎥 : Sean Kitchen #Pennsylvania #PAPolitics #PANews #Harrisburg #HarrisburgPA #CentralPA #CentralPennsylvania #ReproductiveHealthcare #ReproductiveRights #ReproductiveFreedoms #ReproductiveFreedom #PlannedParenthood #BansOffOurBodies #StopTheBans
After expanding health care access for Pennsylvanians, Harris has new plan to cut costs further
After casting the tie-breaking vote for the Inflation Reduction Act, Vice President Kamala Harris is proposing to expand capping the cost of insulin...
Lancaster Dems praise Inflation Reduction Act’s lowering of prescription drug costs
Lancaster County Democrats celebrated the two-year anniversary of the Inflation Reduction Act on Friday. The landmark legislation has helped...
Biden-Harris administration’s Medicare drug price negotiations secure $6 billion in savings for taxpayers
The White House estimates that these new prices will lead to around $6 billion in savings for the Medicare program in 2026. The new prices will be...
Philadelphia retired nurse: I’m saving tens of thousands thanks to a Harris-backed drug cap
In his more than 30 years as a Philadelphia nurse, Steve Lubin often saw patients in intensive care, with organs failing, because they couldn’t...
Major drugmakers capped cost of asthma inhalers at $35 per month after investigation from Democrats
AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline all agreed to cap the price of asthma inhalers earlier this year following an investigation...